What is the price target for SKWD stock?
19 analysts have analysed SKWD and the average price target is 62.68 USD. This implies a price increase of 38.71% is expected in the next year compared to the current price of 45.19.
NASDAQ:SKWD • US8309401029
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SKYWARD SPECIALTY INSURANCE (SKWD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-08 | Barclays | Maintains | Overweight -> Overweight |
| 2026-04-07 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2026-02-27 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2026-02-26 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-06 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-12-05 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-12-04 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-12-04 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-30 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-10-06 | Janney Montgomery Scott | Initiate | Buy |
| 2025-09-08 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-09-04 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-29 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-05-08 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-05-05 | Truist Securities | Maintains | Buy -> Buy |
| 2025-05-05 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-02 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-04-11 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-11 | Jefferies | Downgrade | Buy -> Hold |
| 2025-04-09 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-03-14 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-03-03 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-28 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 875.471M 36.28% | 1.142B 30.50% | 1.419B 24.18% | 1.847B 30.19% | 2.085B 12.89% | 2.332B 11.85% | N/A | N/A | |
| EBITDA YoY % growth | 122.321M 102.85% | 155.148M 26.84% | 246.135M 58.65% | 83.64B 33,881.35% | 91.8B 9.76% | N/A | N/A | N/A | |
| EBIT YoY % growth | 118.43M 110.73% | 151.79M 28.17% | 242.6M 59.83% | 225.88M -6.89% | 248.69M 10.10% | N/A | N/A | N/A | |
| Operating Margin | 13.53% | 13.29% | 17.10% | 12.23% | 11.93% | N/A | N/A | N/A | |
| EPS YoY % growth | 2.10 70.08% | 3.06 45.71% | 4.01 31.05% | 4.97 23.89% | 5.58 12.27% | 6.50 16.49% | 6.95 6.91% | 7.64 9.99% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.18 31.05% | 1.25 39.92% | 1.23 17.44% | 1.32 13.10% | 1.42 20.30% | 1.39 11.82% | 1.32 7.26% | 1.46 10.32% | 1.70 19.90% | 1.63 17.05% | 1.65 25.05% | 1.68 15.18% |
| Revenue Q2Q % growth | 428.34M 30.38% | 452.74M 41.52% | 485.21M 26.84% | 488.29M 26.64% | 505.2M 17.94% | 517.43M 14.29% | 539.28M 11.14% | 542.17M 11.03% | 564.97M 11.83% | 576.87M 11.49% | 590.12M 9.43% | 599.89M 10.65% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 56.558M 13.65% | 57.501M 3.14% | 53.189M -25.20% | 61.924M -6.14% | 74.425M 31.59% | 71.979M 25.18% | 67.662M 27.21% | 77.227M 24.71% | 101.92M 36.94% | 94.71M 31.58% | 96.416M 42.50% | 98.835M 27.98% |
All data in USD
19 analysts have analysed SKWD and the average price target is 62.68 USD. This implies a price increase of 38.71% is expected in the next year compared to the current price of 45.19.
SKYWARD SPECIALTY INSURANCE (SKWD) will report earnings on 2026-04-30.
The consensus EPS estimate for the next earnings of SKYWARD SPECIALTY INSURANCE (SKWD) is 1.18 USD and the consensus revenue estimate is 428.34M USD.
The consensus rating for SKYWARD SPECIALTY INSURANCE (SKWD) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.